Ankylosing Spondylitis Plasma
About: Ankylosing Spondylitis Plasma is collected from donors with clinically confirmed ankylosing spondylitis. Useful for analyzing circulating cytokines, inflammatory markers, and immune-modulating factors in autoimmune arthritis.
| Lot Number | Condition | Volume | Race/Ethnicity | Age | Gender | Country of Collection | Medications | Vials | Price | Action |
|---|---|---|---|---|---|---|---|---|---|---|
| 77405 | Ankylosing Spondylitis | 1.0 ML | Hispanic/Latino | 43 | Female |
None Not taking any medications for hypertension.
|
16 | $495.00 | ||
| 77419 | Ankylosing Spondylitis | 1.0 ML | Caucasian | 46 | Male |
Duloxetine 60 mg QD Remicade Q8 weeks Methotrexate 7.5 mg QD Folic Acid 1 mg QD Modafinil 100 mg QD Olmesartan 40/25 mg QD Meloxicam 15 mg QD
|
13 | $495.00 | ||
| 77876 | Ankylosing Spondylitis | 1.0 ML | Caucasian | 62 | Male |
Taltz/80mg/mL/QM Celebrex/200mg/PRN ( has not taken it in long time) Sulfalsalizine QD
|
11 | $495.00 | ||
| 72201 | Ankylosing Spondylitis | 1.0 ML | Asian/Pacific Islander | 63 | Male |
Amitriptyline 100mg QD Sotyktu 6mg QD Atorvastatin 20 mg QD amlodipine 10mg QD Hydrochlorothiazide 25 mg QD
|
15 | $495.00 | ||
| 71615 | Ankylosing Spondylitis | 1.0 ML | Asian/Pacific Islander | 63 | Male |
Amitriptyline 100mg QD Sotyktu 6mg QD Atorvastatin 20 mg QD amlodipine 10mg QD Hydrochlorothiazide 25 mg QD
|
17 | $495.00 | ||
| 77504 | Ankylosing Spondylitis | 1.0 ML | African American | 67 | Female |
Gabapentin 100 mg TID Enulose Solution Eye Drops TID Timolol 1 gtt QD Kerendia 10 mg QD Adalimumab Injection Q 2 Weeks Rosuvastatin 20 mg QD Esomeprazole 40 mg QD Estradiol 0.1 mg Vaginal Cream Amlodipine-Olmesartan 20/40 mg QD
|
25 | $495.00 | ||
| 76540 | Ankylosing Spondylitis | 1.0 ML | Caucasian | 54 | Female |
Rosuvastatin 40 MG tablet, metoPROLOL succinate 25 MG 24 hr tablet, losartan 50 MG tablet, ezetimibe 10 MG tablet, fluoxetine 60 MG capsule Voquezna 20 MG Tab gabapentin 100 MG capsule Quetiapine 25 MG tablet Xeljanz XR 11 MG TABLET SR 24 HR Phentermine 37.5 mcg QD
|
25 | $495.00 | ||
| 71399 | Ankylosing Spondylitis | 1.0 ML | Caucasian | 82 | Male | United States (US) |
Celecoxib 200mg QD Gabapentin 600mg BID Atorvastatin 20mg QD Metoprolol 25mg QD Tamsulosin 0.4mg QD
|
8 | $495.00 | |
| 71582 | Ankylosing Spondylitis | 1.0 ML | Caucasian Hispanic/Latino | 46 | Male | United States (US) |
Tramadol 50 mg PRN
|
10 | $495.00 | |
| 71484 | Ankylosing Spondylitis | 1.0 ML | Caucasian | 23 | Male | United States (US) |
Naproxyn 500 mg QD
|
7 | $495.00 |
Ankylosing Spondylitis Plasma | High-Quality Human Plasma from Ankylosing Spondylitis Donors
Ankylosing Spondylitis Plasma is collected from donors clinically diagnosed with Ankylosing Spondylitis and processed within hours of collection to preserve key analytes such as cytokines, proteins, and metabolites. This human plasma supports research focused on inflammatory pathways, immune profiling, and biomarker discovery in ankylosing spondylitis pathophysiology.
Product Features
- Research Use Only (RUO)
- Plasma collected from clinically confirmed Ankylosing Spondylitis donors
- Processed within one day of collection
- IRB-approved protocols and informed consent
- Custom aliquot volumes available upon request
De-identified Donor Data
- Verified Ankylosing Spondylitis diagnosis
- Demographic data: age, sex assigned at birth, race/ethnicity
- Donor-reported medications, allergies, and comorbidities
- Additional ankylosing spondylitis-specific metadata available
Applications
- Biomarker discovery and validation
- Cytokine and inflammation profiling
- Metabolomics and proteomics studies
- Therapeutic response research
Compliance and Quality Assurance
- IRB-approved and HIPAA-compliant protocols
- Electronic informed consent with 21 CFR Part 11 – compliant e-signatures
- Documentation support available for regulatory review
Ordering and Customization
Ankylosing Spondylitis plasma is available in standard and custom volumes. For international orders or documentation requirements, please email learnmore@sanguinebio.com to ensure compatibility with your country’s regulations.
Protocols & Documentation
-
Download
Plasma Isolation
Protocol for plasma separation from anticoagulated whole blood, including processing, storage, and traceability requirements.
-
Informed Consent Form (ICF)
Available upon request — confirms donor consent for research use and downstream commercialization.
Plasma
Frequently Asked Questions
1 Answer
All our samples have self-reported infectious disease testing and verified clinical diagnosis. Many of our samples have the option of electronic medical records provided and our prospective collection offers the opportunity for patient reported outcomes and surveys. Learn more here. https://sanguinebio.com/patient-reported-outcomes-pro-surveys-questionnaires/
1 Answer
YES – Certificate of analysis is available upon request.
1 Answer
Lead times vary from ready to ship inventory to prospective studies.
1 Answer
International shipping is available. We also work with a number of distributors. Contact us to discuss options at learnmore@sanguinebio.com.
1 Answer
We have several ordering methods. You can order directly online with a PO or credit card or contact us to have a sales specialist help with your order. https://sanguinebio.com/request-quote/
1 Answer
You can request a quote on this page or contact us at learnmore@sanguinebio.com. https://sanguinebio.com/request-quote/
1 Answer
NO – no minimum order requirements.
1 Answer
For bulk pricing inquiries, please contact: LearnMore@sanguinebio.com
1 Answer
YES – Bulk plasma is available: https://sanguinebio.com/product/human-bulk-plasma/
1 Answer
YES – The “Specify I/E Criteria” service allows you to define specific inclusion/exclusion criteria including lifestyle restrictions.
1 Answer
YES – Sanguine offers longitudinal collections.
1 Answer
YES – Sanguine offers matched samples across multiple matrices and age-matched controls.
Ask a Question
Need a custom Plasma cohort?
Our scientific team can scope prospective collections with donor-specific I/E criteria, typically starting within 2 weeks of agreement.